How India’s SEC Killed Jane Street’s $1B Secret Options Strategy
In April 2024, Wall Street stopped as Jane Street sued Millennium Management over an alleged stolen trading strategy One so lucrative it reportedly earned $1 billion in a single year. The battleground? India’s booming derivatives market. Let’s unpack the hidden mechanics, and the lessons for traders, regulators, and investors worldwide. More in the article...
From Electrical Engineering Classroom to Algo Trading Obsession
15 years ago, I sat next to a stranger in an electric engineering class who showed me a path to trading. I glanced at my neighbor’s laptop and saw a forum called “Nuclear Phynance.” “What’s that?” I whispered. He smirked. “My retirement plan.” Turns out, he was building a fixed-income options strategy to quit the 9-to-5 grind by 30. As a broke student with zero market knowledge, I was hooked. More in the article...
Can Domino’s Pizza Survive the Tariff Wars?
In 2022, as inflation hit 9.1%, Domino’s U.S. sales rose 3% while fine-dining restaurants collapsed. Pizza, after all, is the ultimate recession food: $7.99 feeds a family of four. But in 2025, a new threat emerges, one that pepperoni can’t fix. Trump’s tariff wars on imported dairy would slap Domino’s with millions in annual cheese costs. Suddenly, Wall Street’s favorite “cheap eats” stock faces a brutal math problem: Can a company already drowning in $5.3B debt absorb inflation’s next gut punch? Let’s unravel why DPZ, once considered inflation-proof, is now stuck in financial purgatory. More in the article...
How Insmed Became a Rare Disease Powerhouse
In 2018, a small biotech company you’ve probably never heard of did the impossible: It won FDA approval for the first-ever treatment targeting a deadly lung infection affecting just 15,000 Americans. The drug? Arikayce. The company? Insmed. Today, Insmed operates in 8 countries, employs over 1,000 people, and boasts a pipeline that could redefine care for millions battling rare diseases. More in the article...
Lattice Semiconductor: Story of Bankruptcy, Betrayal, and Second Chances
In 1987, Lattice Semiconductor filed for bankruptcy after burning through $14 million in venture capital. Thirty-seven years later, its survival is a Silicon Forest legend, but its stock is caught in a spiral of contradictions. Revenue is shrinking, tariffs are shifting, and its CEO just jumped ship. Here’s why pressing “hold” is the only move that makes sense. More in the article...
